← Leaderboards
Richard Alan Polin
University Of Pittsburgh At Pittsburgh
$893,006
Attributed
$2,679,017
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $662.2K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,679,017 · 1
By mechanism
R01$2,679,017 · 1
Top collaborators
- Anup C Katheria5 shared
- Michael Morowitz5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael Morowitz$7,157,066
- Masashi Okubo$976,790
- Christopher Warren Seymour$6,573,754
- Salah S Al-Zaiti$5,399,250
- Henry E Wang$15,583,055
Others in their field
Other Emerging Leaders on “Early Diagnosis”
- Ross D McDonald · Florida State University$26,502,247
- Eric C Palm · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Bryan Faller · Decatur Memorial Hospital$26,356,185
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
Research focus
Early DiagnosisAdverse EventAdoptedDoseAnaerobic BacteriaAntibiotic ResistanceAdverse OutcomeAntibiotic TherapyAwardAdverse EffectsBiological MarkersBirthBlindedCare ProvidersAntibioticsCesarean SectionCessation Of LifeChildhoodClinical PracticeClinical Practice PatternsClinical TrialsAmpicillinDesignEarly Onset
Grant awards (5)
The NICU Antibiotics and Outcomes (NANO) Trial$513,445
R01 · FY2023 · HD
The NICU Antibiotics and Outcomes (NANO) Trial$494,999
R01 · FY2022 · HD
The NICU Antibiotics and Outcomes (NANO) Trial$499,628
R01 · FY2021 · HD
The NICU Antibiotics and Outcomes (NANO) Trial$508,740
R01 · FY2020 · HD
The NICU Antibiotics and Outcomes (NANO) Trial$662,205
R01 · FY2019 · HD